Differential release of angiogenic factors from platelets can be manipulated by agents like aspirin, providing a potential mechanism for its impact on malignancy.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for aspirin's anti-angiogenic effects in malignancy via platelets; leaves open clinical translation.
Battinelli et al. (2011) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: